APYX MEDICAL CORP (APYX) Stock Analyst Ratings
NASDAQ:APYX - Nasdaq - US03837C1062 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 78% to APYX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 4.08. This target is 61.9% above the current price.
APYX was analyzed by 9 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about APYX.
In the previous month the buy percentage consensus was at a similar level.
APYX was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-10-17 | BTIG | Initiate | Neutral |
| 2024-09-16 | JMP Securities | Reiterate | Market Perform |
| 2023-11-10 | Stephens & Co. | Maintains | Overweight -> Overweight |
| 2023-08-11 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-07-14 | Stephens & Co. | Initiate | Overweight |
| 2023-06-15 | Lake Street | Maintains | Buy |
| 2023-05-24 | JMP Securities | Reiterate | Market Perform -> Market Perform |
| 2023-05-12 | Lake Street | Maintains | Buy -> Buy |
| 2022-08-12 | Piper Sandler | Maintains | Overweight |
| 2022-07-19 | Lake Street | Maintains | Buy |
| 2022-05-20 | Lake Street | Initiate | Buy |
| 2021-08-13 | JMP Securities | Maintains | Market Outperform |